Integration of point-of-care screening for type 2 diabetes mellitus and hypertension into the COVID-19 vaccine programme in Johannesburg, South Africa

Simple item page
dc.article.end-page11en
dc.article.start-page1en
dc.citation.doi10.1186/S12889-023-17190-6en
dc.contributor.authorAlana Brennanen
dc.contributor.authorB Vetteren
dc.contributor.authorS D Masukuen
dc.contributor.authorB Mtshazoen
dc.contributor.authorN Mashabaneen
dc.contributor.authorSimiso Sokhelaen
dc.contributor.authorWillem Venteren
dc.contributor.authorK Kaoen
dc.contributor.authorGesine Meyer-Rathen
dc.date.accessioned2024-07-23T05:54:39Z
dc.date.available2024-07-23T05:54:39Z
dc.facultyFACULTY OF HEALTH SCIENCESen
dc.identifier.citationWOSen
dc.identifier.urihttps://hdl.handle.net/10539/39069
dc.journal.titleIntegration of point-of-care screening for type 2 diabetes mellitus and hypertension into the COVID-19 vaccine programme in Johannesburg, South Africaen
dc.journal.volume23en
dc.publisherBIOMED CENTRAL LTDen
dc.titleIntegration of point-of-care screening for type 2 diabetes mellitus and hypertension into the COVID-19 vaccine programme in Johannesburg, South Africaen
dc.typeJournal Articleen
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
Journal Article.pdf
Size:
513.71 KB
Format:
Adobe Portable Document Format
Description:
Bitstream uploaded by REST Client
Download
Collections
Academic Wits Research Outputs (All submissions)